tiprankstipranks
Trending News
More News >
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market

Dr Reddy's Laboratories (RDY) Stock Forecast & Price Target

Compare
449 Followers
See the Price Targets and Ratings of:

RDY Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Dr
Reddy's Laboratories
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RDY Stock 12 Month Forecast

There Are No Analyst Ratings for RDY In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

RDY Financial Forecast

RDY Earnings Forecast

Next quarter’s earnings estimate for RDY is $0.14 with a range of $0.10 to $0.22. The previous quarter’s EPS was $0.16. RDY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year RDY has Performed in-line its overall industry.
Next quarter’s earnings estimate for RDY is $0.14 with a range of $0.10 to $0.22. The previous quarter’s EPS was $0.16. RDY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year RDY has Performed in-line its overall industry.

RDY Sales Forecast

Next quarter’s sales forecast for RDY is $931.38M with a range of $884.73M to $983.78M. The previous quarter’s sales results were $979.53M. RDY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year RDY has Performed in-line its overall industry.
Next quarter’s sales forecast for RDY is $931.38M with a range of $884.73M to $983.78M. The previous quarter’s sales results were $979.53M. RDY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year RDY has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

RDY Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
16
16
20
10
14
Hold
13
16
24
18
21
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
32
44
28
35
In the current month, RDY has received 14 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. RDY average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

RDY Stock Forecast FAQ

What is RDY’s average 12-month price target, according to analysts?
Currently, no data Available
What is RDY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RDY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is RDY a Buy, Sell or Hold?
      Currently, no data Available
      What is Dr. Reddy's Laboratories Ltd’s price target?
      Currently, no data Available
      What do analysts say about Dr. Reddy's Laboratories Ltd?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of RDY?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.